Medicine and Dentistry
Age
10%
Asbestos
17%
Asbestos Exposure
20%
Biological Marker
28%
Biopsy
5%
BRCA1
8%
Cancer
10%
Cancer Diagnosis
7%
Cancer Susceptibility
15%
Chemotherapy
31%
Diagnosis
21%
DNA Repair
12%
Effusion
8%
Gene
43%
Genotype
5%
Germline Mutation
18%
Homologous Recombination
10%
Immunohistochemistry
6%
Inpatient
15%
Loss of Function Mutation
5%
Malignant Neoplasm
6%
Marker
18%
Mesothelioma
100%
Neoplasm
20%
Next Generation Sequencing
11%
Odds Ratio
39%
Overall Survival
21%
Patient
71%
Pemetrexed
19%
Platinum
27%
Pleura Mesothelioma
45%
Prevalence
5%
Radiation Therapy
7%
Sarcomatoid
5%
Second Cancer
7%
Single Nucleotide Polymorphism
5%
Specimen
7%
Supportive Care
11%
Survival
31%
Therapeutic Procedure
13%
Tumor Suppressor Gene
8%
Woman
14%
Pharmacology, Toxicology and Pharmaceutical Science
Asbestos Exposure
23%
Biological Marker
28%
Cancer Susceptibility
15%
Effusion
8%
Malignant Neoplasm
6%
Mesothelioma
100%
Neoplasm
20%
Overall Survival
21%
Pemetrexed
19%
Platinum
27%
Pleura Mesothelioma
45%
Prevalence
5%
Survival
31%
Biochemistry, Genetics and Molecular Biology
Age
7%
BAP1
30%
BRCA1
8%
DNA Repair
12%
Electric Potential
7%
Gene Mutation
5%
Genotyping
5%
Germline
11%
Germline Mutation
18%
Homologous Recombination
10%
Loss of Function Mutation
5%
Medline
7%
Mutation
28%
Nested Gene
40%
Overall Survival
11%
Phosphorylase
19%
Prevalence
5%
Sample
8%
Single-Nucleotide Polymorphism
5%
Survival
11%
Tissue Section
5%
